AMAG Pharmaceuticals has stepped in to buy Cord Blood Registry for $700 million, capturing about half of the privately stored cord blood units and taking a prominent position as supplier of stem cells to R&D groups. As Bloomberg notes, this deal further beefs up Waltham, MA-based AMAG's position in the maternal health field, following last November's acquisition of the maternal health unit of Lumara Health. Story